• 首頁
  • 投資者關系
  • 信息披露
  • 社會責任
  • 廣藥動态
  • English
财務指标股本狀況流通股東 治理結構 股東回報情況公平在身邊投資者保護宣傳
定期報告臨時公告
社會責任共享健康權利共建透明商業共繪綠水青山共鑄發展基石我們的故事社會責任暨ESG報告
About UsFinancial HighlightsShare CapitalShareholdersDistribution PlanRegular ReportCSR(社會責任)CSR & ESG Report
  • About Us
  • Financial Highlights
  • Share Capital
  • Shareholders
  • Distribution Plan
  • Regular Report
  • CSR(社會責任)
  • CSR & ESG Report

SUMMARY OF THE 2025 ANNUAL REPORT

2026-03-23 15:34:05

SUMMARY OF THE 2025 INTERIM REPORT

2025-08-16 14:12:40

2025 FIRST QUARTERLY REPORT

2025-04-30 10:28:57

Annual Report 2024

2025-04-11 16:36:42

SUMMARY OF THE 2024 ANNUAL REPORT

2025-03-14 11:05:57

SUMMARY OF THE 2024 INTERIM REPORT

2024-09-02 14:46:39

Annual Report 2023

2024-04-19 08:56:22

SUMMARY OF THE 2023 ANNUAL REPORT

2024-03-16 11:44:20

2023 THIRD QUARTERLY REPORT

2023-10-31 16:49:58

Interim Report 2023

2023-09-12 09:10:29

SUMMARY OF THE 2023 INTERIM REPORT

2023-08-19 09:23:30

Annual Report 2022

2023-04-14 09:25:33

SUMMARY OF THE 2022 ANNUAL REPORT

2023-03-18 14:56:23

2022 THIRD QUARTERLY REPORT

2022-10-26 01:11:24

Interim Report 2022

2022-09-14 01:10:18

關於我們    |    聯系我們

電(diàn)話 :(8620)66281011    傳(chuán)真:(8620)66281229    地址:廣州市荔灣區沙面北街45号

廣州白雲山醫藥集團股份有限公司 版權所有 Copyright © 2000-2020 gybys.com.cn, All Rights Reserved 粵ICP備13064121号